A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia

NCT00459745 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

481

Enrollment

INDUSTRY

Sponsor class

Conditions

Combined Hyperlipidemia

Interventions

DRUG: Pravafen
DRUG: Pravastatin
DRUG: Fenofibrate

Sponsor

Shionogi

Collaborators

[object Object]